维普中文期刊产品整合服务
36篇 您的检索式:作者名="Engelholm"
    题名 作者 年代 出处 被引量
1A proteomics panel for predicting optimal primary cytoreductian in stage Ⅲ/Ⅳ ovarian cancer显示文摘Risum S Hφgdall E Engelholm SA 2009Int J Gynecol Cancer2009,19,9:1
2ExploratoryphaseⅢstudy of paclitaxel and cisplatin versus paclitaxeland carboplatin in advanced ovarian cancer显示文摘Neijt JP Engelholm SA Tuxen MK 2000J Clin On-col2000,18,17:1
3No rules without exception:long term complete remission observed in a study using a LHRH agonist in platinum refractory ovarian cancer显示文摘Paskeviciute L Roed H Engelholm S 2002Gynecol Oncol2002,86,:1
4Exploratory phase I]I study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer 显示文摘Neijt JP Engelholm SA Tuxen MK 2000J Clin Oncol2000,18,30:1
5Positron emission tomography/ computed tomography predictors of overall survival in stage m c/Iv ovarian cancer显示文摘Risum S Loft A Engelholm SA 2012Int J Gynecol Cancer2012,22,7:1
6Intracellular collagen degradation mediated by uPARAP/Endo180 is a major pathway of extracellular matrix turnover during malignancy显示文摘Curino AC Engelholm LH Yamada SS 2005J Cell Biol2005,169,6:1
7uPARAP/endo180 directs lysosomal delivery and degradation of collagen IV显示文摘Kjoller L Engelholm LH Hoyer-Hansen M 2004Exp Cell Res2004,293,1:1
8Exploratory phase Ⅲ study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer显示文摘Neijt JP Engelholm SA Tuxen MK 2000J Clin Oncol2000,18,17:1
9Endoscopic management of cysts and pseudocysts in chronic pancreatitis: Long term follow-up after seven years' experience显示文摘Cremer M Deviere J Engelholm L 1989Gastrointest Endosc1989,35,:1
10No rules without exception: Long-term complete remission observed in a study using a LH-RH agonist in platinum refractory ovarian cancer显示文摘 Roed H Engelholm S 2002Gynecol Oncol2002,86,3:1
11Exploratory phase Ⅲ study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer显示文摘Neijt JP Engelholm SA Tuxen MK 2000J Clin Oncol2000,18,17:1
12Endoscopic management of cysts and pseudocysts in chronic pancreatitis:long term follow up after 7 years of experience显示文摘Cremer M Deviere J Engelholm L 0,,:1
13Urekinase receptor- associated protein (uPARAP) is expressed in connection with malignant as well as benign lesions of the human breast and occurs in specific populations of stromal cells 显示文摘Schnack Nielsen B Rank F Engelholm LH 2002Int J Cancer2002,98,5:1
14Urokinase receptorassociated protein (UPARAP) is expressed in connection with malignant as well as benign lesions of the human breast and occurs in specific populations of stromal cells显示文摘Nielsen BS Rank F Engelholm LH 2002Int J Cancer2002,98,5:1
15Exploratory phase II study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer显示文摘Neijt JP Engelholm SA Tuxen MK 2000J Clin Oncol2000,18,17:1
16Diagnostic accuracy of risk of malignancy index in predicting complete tumor removal at primary debulking surgery for ovarian cancer patients显示文摘Carsten L. Fag?‐Olsen Fanny H?kansson Sofie L. Antonsen Estrid H?gdall Lene Lundvall Lotte Nedergaard Svend A. Engelholm Claus H?gdall 2013Acta Obstet Gynecol Scand2013,,6:1
17Endoscopic management of cysts and pseudocysts in chronic pancreatitis: long-term follow-up after 7 years of experience 显示文摘Cremer M Deviere J Engelholm L 1989Gastrointest Endosc1989,35,1:1
18The urokinase receptor associated protein (uPARAP/endo180): a novel internalization receptor connected to the plasminogen activation system显示文摘Engelholm LH Nielsen BS Dano K 2001Trends Cardiovasc Med2001,11,1:1
19Pancreas divisum:congenital anatomic variant or anomaly? Contribution of endoscopic retrograde dorsal pancreatography 显示文摘DELHAYE M ENGELHOLM L CREMER M 1985Gastroenterology1985,89,:1
20Dis- aggregation of human solid tumor by combind mechanical and enzymatic methods显示文摘Engelholm S A Spang-Thomsen M Brunner N 1985Br J Cancer1985,51,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费